研究者データベース - 細井　創

ホソイ　ハジメ HOSOI Hajime
細井　創

所属同志社女子大学看護学部看護学科

職種特別任用教授

講師・講演
2020/11	シンポジウム　小児難治性固形腫瘍患者を対象としたオラパリブ経口剤の第Ⅰ相臨床試験の開発．Devlopment of phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors. (オンデマンド配信)
2020/11	要望演題　本邦における小児血液・がん患者に対する病名告知、医原性性腺機能不全と不妊症リスクに関する情報提供の現状．Current status of truth telling of cancer diagnosis and risk of iatrogenic gonadal dysfunction/infertility to Japanese childhood and adolescent patients. (オンデマンド配信)
2020/11	ＷＩＴＨコロナの時代、感染症にどう向き合うか？小児の皆さん、保護者の皆様へ～小児科医師から～． (オンデマンド配信)
2019/11	High-fat diet accelerates extreme obesity with hyperphagia and severe glucose intolerance in female heterozygous Mecp2 null mice. (Boston, Massachusetts, USA)
2019/10	Development of PiggyBac Transposon Mediated CAR-T Cells Targeting EPHB4 for Pediatric Solid Tumors. (Lyon, FRA)
2019/07	パネルディスカッションコーディネーター　小児がん拠点病院における高校生等への教育サポート. (京都)
2019/04	Optimization of PiggyBac Transposon-Based Gene Delivery by the MaxCyte Scalable Transfection System for Manufacturing Chimeric Antigen Receptor-T Cells. (Washington D.C.USA)
2019/02	Development of chimeric antigen receptor T cell therapy for human rhabdomypsarcoma. (Osaka, Japan)
2018/12	A novel PAX5-KIDIND220 fusion protein activates multiple signals associated with therapeutic resistance. (San Diego, CA, U.S.A.)
2018/12	Coagulation and fibrinolysis imbalance demonstrated by novel simultaneous thrombin and plasmin generation assay during L-asparaginase treatment phase of induction therapy in pediatric acute lymphoblastic leukemia. (San Diego, CA, U.S.A.)
2018/12	Leukemic cell expressing a novel kinase fusion protein NCOR1-LYN exhibits high sensitivity to dasatinib and rapamycin. (San Diego, CA, U.S.A.)
2018/11	Meet The Expert 6. Tumor board. Sarcoma. (Kyoto, Japan)
2018/11	シンポジウム．小児がん放射線治療における性機能温存のための性線移動の役割．Gonadal-preservation surgery with radiation therapy for childhood cancer. (京都)
2018/11	シンポジウム．横紋筋肉腫に対する新たな治療戦略．New therapeutic strategy for rhabdomyosarcoma. (京都)
2018/11	会長講演　狭き門より． (京都)
2018/11	特別シンポジウム．日本横紋筋肉腫研究グループ第１期臨床試験の結果と第２期臨床試験の戦略．Results from the first Japanese Rhabdomyosarcoma Group Study (JRS-Ⅰ) and the strategy for the next treatment protocol (JRS-Ⅱ). (京都)
2018/11	英語口演．当院における小児頭蓋外悪性胚細胞腫瘍の臨床的検討．Long-term outcomes of pediatric extracranial malignant germ cell tumors-A single center 18 years experiences-. (京都)
2018/11	英語口演．横紋筋肉腫に対する新規 RAF/MEK デュアル阻害剤の検討．Novel allosteric RAF/MEK inhibitor in the treatment of rhabdomyosarooma. (京都)
2018/11	英語口演．胎児型横紋筋肉腫におけるFGFR4経路の変異．FGFR4 pathway mutations in embryonal type of Rhabdomyosarcoma. (京都)
2018/09	Effectiveness of ultrasonography for myositis screening in clinically amyopathic juvenile dermatomyositis: a case series. (Lisbon, Portugal)
2018/05	Identification and characterization of a novel NCOR1-LYN fusion gene in pediatric B-cell precursor acute lymphoblastic leukemia with IKZF1 deletion. (Helsinki, Finland)
2018/05	Serious heart failure associated with non-compaction cardiomyopathy in a baby of double outlet of right ventricle with left isomerism. (Nara, Japan)
2018/04	分野別シンポジウム．小児・若年成人がん患者への妊孕性温存治療診療ガイドラインについて． (福岡)
2018/02	小児領域におけるがん・生殖医療． (東京)
2017/11	シンポジウム. 小児がん患者の妊孕性温存に関する診療ガイドライン. (愛媛)
2017/10	Interim Results of a Clinical Trial of IDRF for Intermediate-Risk Neuroblastoma from the Japan Neuroblastoma Study Group (JNBSG). (Washington DC,USA)
2017/10	Mutation of RAS pathway should be a target of precision medicine for rhabdomyosarcoma. (Washington DC,USA)
2017/10	The novel histone deacetylase inhibitor OBP-801 induces apoptosis in neuroblastoma tumor cells. (Tokyo Japan)
2017/09	Vitamin D deficiency is prevalent in short stature children with underlying illness. (Washington DC, USA)
2017/09	“Ang 1-7 exerts anti-obesity effect through proliferation of BAT.” (Washington DC, USA)
2017/08	特別講演 Children First! 子どもたちが教えてくれる未来の医療と社. (京都)
2017/04	分野別シンポジウムここまで進歩した小児白血病・がんに対する治療法. 小児固形がん治療の進歩と展望. (東京)
2017/03	6-color-based HLA-Flow method for the monitoring of minimal residual disease and chimerism after HLA-mismatched allogeneic hematopoietic cell transplantation in children. (Marseille, France)
2016/12	プレナリーセッション. Integrative genome-wide analysis of pancreatoblastoma. (東京)
2016/11	An ectopic parathyroid adenoma with hypercalcemia in a child. (Tokyo, Japan)
2016/11	Erythropoietin ameliorates obesity and glucose intolerance on high fat dietary obese mice through the activation of erythropoietin receptor/STAT3 pathway and the up-regulation of FGF21 secretion on classical brown adipose tissue. (Tokyo, Japan)
2016/11	PAX3-FOXOa KNOCKDOWN REDUCES PD-L1 EXPRESSION IN AN ALVEOLAR RHABDOMYOSARCOMA CELL LINES. (Lisbon, Portugal)
2016/10	A PHASE II STUDY OF BOLD DELAYED LOCAL CONTROL STRATEGY IN CHILDREN WITH HIGH RISK NEUROBLASTOMA : JAPAN NEUROBLASTOMA STUDY GROUP (JN-H-11) TRIAL. (Dublin, Ireland)
2016/10	GENOME-WIDE MULTI-OMIC ANALYSIS OF PAEDIATRIC PANCREATOBLASTOMA. (Dublin, Ireland)
2016/10	INTENSIFIED INDUCTION CHEMOTHERAPY FOLLOWED BY HIGH-DOSE CHEMOTHERAPY FOR CHILDREN WITH GROUP 3 ALVEOLAR RMS AND GROUP 4 RMS. (Dublin, Ireland)
2016/10	MET/ERK2 PATHWAY REGULATES THE MOTILITY OF HUMAN ALVEOLAR RHABDOMYOSARCOMA CELLS. (Dublin, Ireland)
2016/10	PROGNOSTIC IMPACT OF PATHOLOGICAL CLASSIFICATION AND FUSION GENE STATUS IN PAEDIATRIC RHABDOMYOSARCOMA FROM THE JAPAN RHABDOMYOSARCOMA STUDY GROUP (JRSG). (Dublin, Ireland)
2016/10	特別講演我が国の小児がん治療研究について. (京都)
2016/09	Assessment of entheseal ultrasonography in patients with juvenile fibromyalgia. (Genoa, Italy)
2016/09	Erythropoietin activates classical brown adipose tissue through the erythropoietin receptor/ STAT3 pathway, improving obesity and glucose homeostasis in high fat diet-induced obese mice. (Paris, France)
2016/09	The collapse of BDNF/POMC system is responsible for the extreme obesity with hyperphagia in female MeCP2 knockout mice fed with high-fat diet. (Paris, France)
2016/08	Longitudinal change in white matter in preterm infants without magnetic resonance imaging abnormalities: Assessment of serial diffusion tensor imaging and their relationship to neurodevelopmental outcomes. (Melbourne, Australia)
2016/06	A novel histone deacetylase inhibitor OBP-801 induces apoptosis in neuroblastoma tumor cells. (Queensland, Australia)
2016/06	Opsoclonus-myoclonus syndrome in neuroblastoma: A report from the Japan Neuroblastoma Study Group (JNBSG). (Queensland, Australia)
2016/05	The treatment of RMS: the strategy of the Japanese Group. (Barcelona, España)
2016/05	基調講演小児固形がん臨床研究における外科療法標準化への期待. (福岡)
2016/02	特別講演神経芽腫マス・スクリーニングの過去・現在・未来. (北海道)
2015/12	Analysis of copy number abnormalities of 86 aacute lymphoblastic leukemia cell lines based on the genetic subtypes. (Orlando Florida, FL, U.S.A.)
2015/12	当科および関係施設での小児ALLの造血細胞移植の成績と問題点. (京都)
2015/11	English Session．CD146 is a promising target for immunotherapy against malignant rhabdoid tumoes． (甲府)
2015/11	Identification of novel BOC-PLAG1 fusion gene and Importance of the Cytogenetic Approach Using PLAG1 in Diagnosis of Lipoblastoma. (Salt lake city, USA)
2015/11	RESULTS OF THE JAPAN RHABDOMYOSARCOMA STUDY GROUP JRS-I LRB0401 PROTOCOL, USING VINCRISTINE, DACTINOMYCIN AND CYCLOPHOSPHAMIDE AND RADIATION THERAPY, FOR LOW-RISK EMBRYONAL RHABDOMYOSARCOMA. (Salt lake city, USA)
2015/11	シンポジウム4小児ならびにAYA 世代腫瘍に対する放射線療法の進歩. 小児がん放射線治療の課題と期待　～小児科医の立場から～. (甲府)
2015/11	ワークショップ．胞巣型横紋筋肉腫細胞株Rh30において、PAX3-FOXO1ノックダウンはPDL1発現を低下させる. (甲府)
2015/10	Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen for dyskeratosis congenita: experience of our institutes. (Aarhus, Denmark)
2015/10	Erythropoietin activates thermogenesis and improves glucose intolerance by upregulating PRDM16 of brown adipose tissue in high fat-diet induced obese mice. (Brisbane, Australia)
2015/10	Isogenic iPSCs from an individual with SCN1A mutation mosaicism revealed aberrant dopamine levels in Dravet syndrome neurons. (Chicago, USA)
2015/10	Mislocalization of syntaxin-1 and impaired neurite growth observed in a human iPSC model for STXBP1-related epileptic encephalopathy. (Chicago, USA)
2015/10	The relationship between ghrelin gene (GHRL) polymorphisms and obesity among Japanese children in Kyoto-Japan. (Brisbane, Australia)
2015/07	17歳のB前駆細胞型ALLの一例. (京都)
2015/05	Diagnostic and prognostic role of circulating miR-206 in rhabdomyosarcoma patients. (Chicago, USA)
2015/05	Refractory epileptic encephalopathy in a case with cardio-facio-cutaneous syndrome caused by MAP2K1 mutation. (Taipei, Taiwan)
2015/05	特別講演小児科学と小児科診療から学んだこと． (滋賀)
2015/05	講演小児医療と小児科医のこころ． (京都)
2015/01	イントロダクションわが国の小児がん医療の歴史と現状． (京都)
2015/01	教育講演横紋筋肉腫第Ⅱ世代全国スタディ(JRS-Ⅱ)プロトコルの概要とその背景と根拠． (埼玉)
2014/12	Clinical significance of LNK (SH2B3) expression in pediatric B cell precursor acute lymphoblastic leukemia. (San Francisco, CA, U.S.A.)
2014/10	Circulating microRNA expression profiles identify patients with metastatic rhabdomyosarcoma. (Berlin, Germany)
2014/10	CLINICAL FINDINGS OF ONCOLOGIC EMERGENCY AT DIAGNOSIS. (Toronto Canada)
2014/10	Deciphering the mechanism of PAX3-NCOA2 tumorigenes is in rhabdomyosarcoma. (erlin, Germany)
2014/10	RESULTS OF THE JAPAN RHABDOMYOSARCOMA STUDY GROUP JRS-I LRA0401 PROTOCOL, USING VINCRISTINE, DACTINOMYCIN AND CYCLOPHOSPHAMIDE AND RADIATION THERAPY, FOR LOW-RISK EMBRYONAL RHABDOMYOSARCOMA. (Toronto, Canada)
2014/10	VALIDITY AND RELIABILITY OF IMAGE-DEFINED RISK FACTORS IN LOCALIZED NEUROBLASTOMA: A REPORT FROM 2 TERRITORIAL CENTERS IN JAPAN. (Toronto Canada)
2014/09	Miglitol upregulates uncoupling protein 1 (ucp1) by enhancing β-adrenergic signaling in mature brown adipocytes of rat. (Dublin, Ireland)
2014/09	The association of Ghrelin Gene Polymorphism with Obesity in Japanese Children. (Dublin, Ireland)
2014/09	特別講演. 小児悪性固形腫瘍の課題と展望. (岡山)
2014/08	Meet in PAL. 小児がん. (横浜)
2014/08	シンポジウム. 成人期に発症する『小児がん』とわが国のAYA世代がんの現況. (横浜)
2014/08	パネルディスカッション. 神経芽腫マススクリーニングを考える患者血清による腫瘍遺伝子診断を活用した乳児神経芽腫の治療. (広島)
2014/08	教育セッション. 小児がん. (横浜)
2014/05	Is Additional Treatment Necessary for a Residual Tumor in Cases of Intermediate-Risk Neuroblastoma? (Cologne,Germany)
2014/05	Surgical Intervention Strategies for Mediastinal Neuroblastic Tumors in Children. (Cologne, Germany)
2014/04	Background and Project for Rhabdomyosarcoma Study in Japan. (（於　Seoul, Korea.）)
2014/04	Serum miR-206 as novel biomarker for rhabdomyosarcoma. (（於　Seoul, Korea.）)
2014/04	The Japan Rhabdomyosarcoma Study Group(JRSG): Preliminary Results from the JRS-1 Study and Background for the Next JRS-2 Treatment Protocols. (（於　Seoul, Korea.）)
2014/03	特別講演. 我が国の小児がん診療における小児がん拠点病院の役割について. (大阪)
2013/12	ABT-737 restores prednisolone sensitivity in early T-cell precursor acute lymphoblastic leukemia with high MEF2C expression. (New Orleans, LA, U.S.A.)
2013/12	Loss of NOXA expression by INI1/SNF5 loss impaired sensitivity to chemotherapeutic agents in malignant rhabdoid tumor. (Paris, France)
2013/12	MLL-AF9 positive acute myeloid leukemia cells are sensitive to all-trans retinoic acid. (New Orleans, LA, U.S.A.)
2013/12	SSNH5/INI1 deficiency destabilizes the SWI/SNF complex during malignant rhabdoid tumor development. (Paris, France)
2013/11	Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice. Neuroscience 2013. (San Diego,California, U.S.A.)
2013/11	FLAG-IDA-gemtuzumab ozogamicin (GO) before hematopoietic stem cell transplantation for refractory AML. (Fukuoka.Japan)
2013/11	High serum miR-206 expression level is correlated with metastatic status. (Fukuoka.Japan)
2013/11	シンポジウム“小児とAYA世代の肉腫：診断、治療、拠点整備の現状と展望”. (大阪)
2013/11	プレナリーセッション　Function analysis of NOXA expression in malignant rhabdoid tumor． (福岡)
2013/11	教育セッション　軟部組織肉腫治療研究の現況． (福岡)
2013/10	Idiopathic colitis complicated with XIAP deficiency. (Tokyo, Japan)
2013/10	Review of seven cases of congenital absence of portal vein (CAPV) in a single medical institution. (Tokyo, Japan)
2013/10	小児科医から見た　子育て． (京都)
2013/10	軟部組織肉腫治療戦略アップツーデート． (京都)
2013/09	Cliniccal feartures and surgical intervention of primary mediastinal tumors in children: A 25-year single institution experience. (Hong Kong, China)
2013/09	Does the residual tumor mass in the intermediate risk neuroblastoma influence the prognosis? (Hong Kong, China)
2013/09	High serum mir-206 expression levels define an aggressive rhabdomyosarcoma subtype. (Hong Kong, China)
2013/09	Miglitol increases energy expenditure by up-regulation uncoupling protein 1(UCP1) in brown adipose tissue　(BAT) of diet-induced obesity mice. (Milan, Italy)
2013/09	Optimizing growth hormone therapy by dose titration in short children born small for gestational age. (Milan, Italy)
2013/08	成人期に発症する小児がんの対応について． (京都)
2013/07	各種がん検診・診断における新技術と応用の可能性　神経芽腫の新たなバイオマーカー検診の提案． (群馬)
2013/06	忘れられたがんに光を～成人期に発症した小児がん～． (福島)
2013/03	わが国の小児がん診療と小児がん専門医の育成、今後の展望について． (京都)
2013/01	医療機関で遭遇する児童虐待の実態と対応（医療現場の現状/行政との連携）． (滋賀)
2012/12	LSD1 inhibitor activates retinoic acid pathway in MLL fusion positive acute myeloid leukemia. (Atlanta, GA, U.S.A.)
2012/11	Management of chemotherapy-induced nausea and vomiting (CINV) in children –Aprepitant use and parenteral nutrition-. (Yokohama)
2012/11	Tumor-Specific Cooperation of Retinoblastoma Protein Family and Snf5 Inactivation in Malignant Rhabdoid Tumor: The Clarification of Tumorgenesis Using Mouse Models. (横浜)
2012/10	Clinical features and surgical intervention of renal tumors diagnosed during early infancy. (London, United Kingdom)
2012/10	hSNF5 reexpression in malignant rhabdoid tumors regulates the transcription of NOXA and p21CIP1/WAF1 by recruitment of SWI/SNF complexes and RNAPII to their promoters. (London, UK)
2012/10	Successful treatment for osteosarcoma patients under 25 years of age. (London, UK)
2012/10	Surgical strategies for hepatoblastomas with pretext III or IV. (London, United Kingdom)
2012/10	The utility of cystatin C for evaluation of renal function in pediatric cancer patients. (London, UK)
2012/10	Validation of serum MIR-206 expression level as a diagnostic biomarker for rhabdomyosarcoma: A report of the Children’s Oncology Group study ARST12B1. (London, United Kingdom)
2012/09	miRNAs as serum biomarkers for RMS. SOFT TISSUE SARCOMA COMMITTEE, Biology Session, (（於　Atlanta, USA.）)
2012/09	児童虐待における医療と行政のより良い連携とは―児童虐待に関するアンケート調査結果． (京都)
2012/07	The relationship between diffusion parameters of the corpus callosum and developmental outcome in preterm infants. (Halifax, Canada)
2012/07	小児難治性悪性疾患のトランスレーショナルリサーチ． (青森)
2012/06	Genomic evaluation in relapsed neuroblastoma. (Toronto, Canada)
2012/06	Prospective evaluation of MYCN gene amplification status using serum DNA of neuroblastoma patients. (Toronto, Canada)
2012/06	The expression of retinoic acid related genes in neuroblastoma can predict the patients’ prognosis. (Toronto, Canada)
2012/06	The prospective risk can stratified in various neuroblastoma groups: statistical analysis on the data over than 3 decades in Japan. (Toronto, Canada)
2012/05	Dual Role of PAX3-NCOA2 in Tumorigenesis of Rhabdomyosarcoma. (Auckland, New Zealand)
2012/03	横紋筋肉腫のリスク分類と治療の動向． (大阪)
2012/02	小児難治性悪性疾患の病態解明と診断・治療の応用． (和歌山)
2011/11	小児固形腫瘍の治療における生検の果たす役割． (群馬)
2011/10	Effects of chemotherapy on the brain in childhood: diffusion tensor imaging of subtle white matter damage. (Brisbane, Australia)
2011/10	F-18 FDG-PET/CTが不明熱の鑑別と診療方針決定に有用と考えられた１症例． (神戸)
2011/10	Muscle-specific microRNA: a novel body fluid biomarker for diagnosis of rabdomyosarcoma. (Auckland, New Zealand)
2011/10	Prognosis of neuroblastoma patients less than eighteen months old using serum-based quantification of MYCN gene amplification. (Auckland, New Zealand)
2011/05	Cerebellar peduncles injury in preterm infants with cerebral palsy as detected by quantitative tractography. (Cavtat, Croatia)
2011/04	Dual role of PAX3-NCOA2 in tumorigenesis of rhabdomyosarcoma. (Orlando, U.S.A.)
2011/02	医療機関で遭遇する児童虐待の実態と対応． (滋賀)
2011/02	小児悪性固形腫瘍のトランスレーショナルリサーチ． (山梨)
2011/02	横紋筋肉腫治療の現状と展望． (沖縄)
2010/12	RAD001, an inhibitor of mTOR, enhances monocytic differentiation induced by ATRA through phosphorylation of C/EBPαin AML cell lines. (Orlando, Florida, U.S.A.)
2010/12	Specific MLL fusion partners affect the sensitivity of human and murine leukemic cell lines to demethylating agents. (Orlando, Florida, U.S.A.)
2010/10	Childhood Cancer Survivorship． (京都)
2010/10	Muuscle specific microRNAs as novel biomarkers for rhabdomyosarcoma. (Boston, Massachusetts, U.S.A)
2010/10	『集学的治療、トータルケア』って何？ (京都)
2010/10	小児がん経験者、保護者たちと語る． (京都)
2010/10	横紋筋肉腫の初診時診断と初期治療導入方針の重要性について． (京都)
2010/07	検診の実施間隔についての過激な提言神経芽腫がん検診のあり方についての検討． (東京)
2010/07	神経芽腫スクリーニングの正しい評価と今後京都府における18ヵ月マス・スクリーニング． (東京)
2010/06	Identification of therapy-sensitive subtype and stratification of progressive risk in adabenced neurobalsrtoma. (Stockholm Sweden)
2010/06	Preoperative analysis of 11q loss of heterozygosity using circulating tumor-released DNA in serum: A novel diagnostic tool for therapy stratification of neuroblastoma. (Stockholm Sweden)
2010/06	Results of treatment strategy of stage 4 infantile neuroblastoma based on born metastasis and MYCN amplification. (Stockholm Sweden)
2010/05	Quantitative tractography assessment of corpus callosum in preterm infants at term-equivalent age. (Cairo, Egypt)
2010/02	横紋筋肉腫治療の現況と展望． (福岡)
2009/12	Monocytic differentiation of myeloid leukemia cell lines induced by ATRA and 5-Aza-2’-Deoxycitidine． (ew Orleans，Louisiana，USA)
2009/11	神経芽腫マススクリーニングの再評価と今後－なぜ休止され、なぜ今また見直されようとしているのか？－． (福井)
2009/11	自閉症と発達障害－治すのではなく、直される病気？－． (京都)
2009/09	我が国の横紋筋肉腫治療の過去・現在・未来． (金沢)
2009/06	Diffusion tensor MRI study in a patient with juvenile-onset vanishing white matter disease． (Daegu，Korea)
2009/06	京都府の新生児医療における京都府立医科大学附属病院周産期診療部NICUの取り組み． (京都)
2009/02	全身に発生する小児がんの治療戦略：スペシャリストの共同作業． (大阪)
2009/02	神経芽腫マススクリーニングの再評価と今後－なぜ休止され、なぜ今また見直されようとしているのか？－ (京都)
2008/11	The later effects of stress reaction depending on the developmental stage. (Washington DC, USA.)
2008/10	Antitumor activity of Gefitinib and Trastuzumab effecting on EGFR receptor in malignant rhabdoid tumor cells. (Berlin, Germany)
2008/10	Detection of IGF2 and H19 imprinting abnormalities in rhabdomyosarcoma patients using tumor and serum DNA. (Berlin, German)
2008/10	EVALUATION OF PROGNOSIS AND EFFICACY OF THERAPY FOR NEUROBLASTOMA PATIENTS BY QUANTIFICATION OF METHYLATED DCR2 GENE PROMOTER IN SERUM DNA. (Berlin, German)
2008/10	p53 restoration therapy in pediatric rhabdomyosarcoma. (Berlin, German)
2008/10	PD 0332991 Inhibits Cell Proliferation And Induces Ｇ1Cell Cycle Arrest against Malignant Rhabdoid Tumor Cells Which Constitutively Express p16Ink4a at ａ Low Level. (Berlin, German)
2008/10	THE PROGNOSIS OF STAGE 4S NEUROBLASTOMA OF 12 MONTHS OLD AND OVER REALY EXCELENT? (Berlin, German)
2008/10	我が国の横紋筋肉腫治療と現状と次世代の診断・治療への展望． (京都)
2008/09	小児腫瘍性疾患の予後を左右する初診時対応の重要性について． (京都)
2008/08	小児難治性がんの病態解明と分子標的治療薬の開発． (京都)
2008/07	小児科医と子育て． (神戸)
2008/05	A Review of Our Twenty-year Experience with Established Neuroblastoma Cell Lines. (Chiba, Japan.)
2008/05	Low-dose protracted irinotecan as a palliative chemotherapy for advanced neuroblastoma. (Chiba, Japan.)
2008/05	Methylation Analysis of DCR2 gene Using Tumor and Serum DNA of Neuroblastoma Patients. (Chicago, USA)
2008/05	Methylation Analysis of DCR2 gene Using Tumor and Serum DNA of Neuroblastoma Patients. Advances in Neuroblastoma Research 2008. (Chiba, Japan.)
2008/05	MYCN Amplified Neuroblastoma in Infants: From The Japanese Infantile Neuroblastoma Cooperative Study. (Chiba, Japan.)
2007/11	Specific inhibition of the PAX3-FKHR fusion gene by small interfering RNA decreases proliferation and motility, but promotes differentiation in human alveolar rahbdomyosarcoma cells. (Mumbai, India.)
2007/11	Trastuzumab significantly enhances the antibody-dependent cellular cytotoxicity effect against malignant rhabdoid tumor cells. (Mumbai, India.)
2007/10	Induction of terminal differentiation in alveolar rhabdomyosarcoma cells by inhibiting both CDK4/6 and CDK2 activities. (（於　Yokohama, Japan.）)
2007/10	予後不良小児悪性腫瘍，胞巣型横筋肉腫の分子遺伝学的特徴と診断と治療への応用．ワークショップ：小児悪性腫瘍におけるトランスレーショナルリサーチ． (京都)
2007/08	Serum levels of MYCN amplification in neuroblastoma using tumor-released DNA by real-time quantitative PCR. (Athens, Greece.)
2007/04	予後不良小児がん，胞巣型横紋筋肉腫の病態解明と診断・治療への応用． (京都)
2007/03	アメリカの子育て・日本の子育て． (京都)
2005/03	小児科で関わる難病と、私の日常の取り組み． (京都)